Nuo Therapeutics, Inc. (AURX) Financials
AURX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 1.9 million | 3.3 million |
| Dec. 31, 2025 | 1.8 million | 2.8 million |
| Sept. 30, 2025 | 1.9 million | 2.3 million |
| June 30, 2025 | 1.4 million | 2.2 million |
AURX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -785119 | 23527 |
| Dec. 31, 2025 | -465851 | 23527 |
| Sept. 30, 2025 | -706516 | 19915 |
| June 30, 2025 | 260699 | 23201 |
AURX Net Income
No data available :(
AURX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 263827 | 820000 | - |
| Dec. 31, 2025 | 548946 | 20936 | - |
| Sept. 30, 2025 | 514797 | 40757 | - |
| June 30, 2025 | 316354 | - | 131608 |
AURX Shares Outstanding
AURX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 847 | - | 1.3 million | - |
| Dec. 31, 2025 | 43205 | - | 1.3 million | - |
| Sept. 30, 2025 | 4 | - | 1.2 million | - |
| June 30, 2025 | 1667 | - | 1.2 million | - |
AURX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 1.3 million | 452388 |
| Dec. 31, 2025 | 1.1 million | 408461 |
| Sept. 30, 2025 | 1.0 million | 406721 |
| June 30, 2025 | 700202 | 159350 |
AURX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
AURX
Price: $1.06
52 week price:
Earnings Per Share: -0.05 USD
P/E Ratio: -28
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 57.9 million